CLINICAL PATHWAYS FOR ACUTE CARE IN TASMANIAN EMERGENCY DEPARTMENTS
With Associate Professor Viet Tran, Deputy Director of Emergency Medicine at Royal Hobart Hospital & Founding Director, Tasmanian Emergency Medicine Research Institute & Emergency Medicine Discipline Lead, University of Tasmania, Tasmania, Australia
RESEARCHER PROFILE
Filmed in Hobart, Australia | July 2025
Viet Tran is Associate Professor of Emergency Medicine at the University of Tasmania, Founding Director of the Tasmanian Emergency Medicine Research Institute, Deputy Director of Emergency Medicine at Royal Hobart Hospital, Chair of the Tasmanian Emergency Departments Network and Inaugural Co-Chair of the Tasmanian Health Senate.
A/Prof Tran also works at the coalface of healthcare as an Emergency Physician and continually advocates for excellence in patient care through education, research, quality and safety and health reform.
He has built Emergency Medicine Research in Tasmania from the ground up, which has culminated in the success of a AUD$3 million Australian Government Medical Research Futures Fund grant looking into the Implementation of Clinical Pathways for Acute Care in Tasmania project. Dr Tran is also the Emergency Medicine Discipline lead within the Tasmanian School of Medicine and has key roles to play within Emergency Medicine training. He feels privileged to be able to teach and mentor across the whole spectrum of becoming a doctor, from watching students grow into junior doctors, senior registrar and as fellow medical specialists.
Source: University of Tasmania website
-
Dr Jasmine Kaur
RESEARCH IN SPINAL CORD INJURY
@ GRIFFITH UNIVERSITY, QUEENSLAND, AUSTRALIA -
Identification, characterisation and role of leader cells in ovarian cancer progression
Dr. Maree Bilandzic is a molecular cancer biologist dedicated to advancing the understanding and treatment of ovarian cancer (OC). Her research addresses critical gaps in OC treatment by investigating the mechanisms behind metastasis, chemotherapy resistance, and tumour recurrence. By utilising innovative methodologies and disease-representative models, Dr. Bilandzic has pioneered the identification and characterisation of leader cells (LCs)—a unique, stem-like subpopulation within tumours that plays a crucial role in OC progression.
-
Oral administration of insulin for Type 1 Diabetes
Huiwen Pang is a 3rd year PhD candidate in the Australian Institute for Bioengineering and Nanotechnology, University of Queensland, focusing on biomedical health research. Prior to commencing his PhD, Huiwen studied animal genetics in his Masters degree at Huazhong Agriculture University in China.
People with diabetes, especially Type 1 diabetes, largely rely on the insulin injections or insulin pumps to control their high blood glucose levels, which is painful and has a high risk of infections.
Huiwen Pang is conducting research on nano-based drug formulations for Type 1 diabetes treatment, with a focus on using nanomaterials to load insulin for oral administration and employing anti-apoptotic and anti-inflammatory approaches to mitigate damage to beta cells.
